December 13, 2018 GLATECT(TM) IS NOW COVERED BY THE PROVINCIAL DRUG PLAN IN BRITISH COLUMBIA FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS). Read More
February 20, 2018 Pendopharm a division of Pharmascience signs an agreement with Cosmo Pharmaceuticals Read More
